Surfactant therapy in the absence of respiratory support facilities [2]

Journal of Tropical Pediatrics

Volumn 49, Issue 1, 2003, Pages 61-63

  El Amin, Eisa Osman ^a   Sharma, Padam P ^b  

^a KHOULA HOSPITAL   (Oman)

^b SQH Hospital   (Oman)

Author keywords

[No Author keywords available]

Indexed keywords

LUNG SURFACTANT; LUNG SURFACTANT EXTRACT; OXYGEN;

APGAR SCORE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; FEMALE; GESTATIONAL AGE; HUMAN; INTUBATION; LETTER; MALE; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OXYGEN THERAPY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; SURVIVAL; THORAX RADIOGRAPHY;

EID: 0037325861     PISSN: 01426338     EISSN: None     Source Type: Journal    
DOI: 10.1093/tropej/49.1.61-a     Document Type: Letter

References (15)

1. Kuint J, Reichman B, Neumann L, Shinwell ES. Prognostic value of the immediate response to surfactant. Arch Dis Child Fetal Neonatal Ed. 1994; 71: 170-73.
2. Hoekstra RE, Ferrara TB, Rayne NR. Effects of surfactant therapy on outcome of extremely premature infants. Eur J Pediatr 1994; 153 (Suppl. 2): 12-6.
3. Lim NL, Nordin MM, Cheah IG. Surfactant therapy in respiratory distress syndrome. Med J Malaysia 1994; 49: 4-11.
4. Survanta Multidose Study Group. Two year follow up of infants treated for respiratory distress syndrome with bovine surfactant. J Pediatr 1994; 124: 962-67.
5. Schwarz RM, Luby AM, Scanlon JW, Kellog RJ. Effect of surfactant on morbidity, mortality and resource use in neoborn infants weighing 500 to 1500 gram. N Engl J Med 1994: 330: 1476-80.
6. Mauskopf JA, Backhouse ME, Jones D, et al. Synthetic surfactant for rescue treatment of respiratory distress syndrome in premature infants weighing from 700 to 1300 grams: impact on hospital resource use and charges. J Pediatr 1995; 126: 94-101.
7. Verder H, Robertson B, Greisen G, et al. Surfactant therapy and nasal continuous positive airway pressure for newborns with respiratory distress syndrome. Danish-Swedish multicentre study group. N Engl J Med 1994; 331: 1051-55.
8. So BH, Tamura M, Kamoshita S. Nasal continuous positive airway pressure following surfactant replacement for the treatment of neonatal respiratory distress syndrome. Acta Pediatr Sin 1994; 35: 280-87.
9. Billman D, Nicks J, Schumacher R. Exosurf rescue surfactant improves high ventilation-perfusion mismatch in respiratory distress syndrome. Pediatr Pulmonol 1994; 279: 83.
10. Baraldi E, Pettenazzo A, Filippone M, Magagnin GP, Saia OS, Zacchello F. Rapid improvement of static compliance after surfactant treatment in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 1993; 15: 157-62.
11. Cotton RB, Olsson T, Law AB, et al. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease. Pediatr Res 1993; 34: 495-501.
12. The OSIRIS collaborative group. Open study of infants at high risk of respiratory insufficiency - the role of surfactant. Lancet 1992; 40: 1363-69.
13. Yuksel B, Greenough A. The effect of exogenous surfactant replacement therapy on lung function. Turk J Pediatr 1993; 35: 53-7.
14. Jobe AH, Mitchell BR, Gunkell JH. Beneficial effect of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynecol 1993; 168: 508-13.
15. Kari MA, Hallman M, Teramo K, Vertanen M, Koivisto M, Ikonen RS. Prenatal dexamethazone treatment in conjunction with rescue therapy of human surfactant: A randomised placebo-controlled multicentre study. Pediatrics 1994; 93: 730-36.